Skip to main content
. 2020 May 25;23:100353. doi: 10.1016/j.eclinm.2020.100353

Table A3.

Geometric mean antibody concentration (GMC) for HPV-16 and HPV-18 antibodies in subjects seronegative at baseline by ELISA (TVC).

anti-HPV-16 antibody (IU/mL) AS04-HPV-16/18 WLWH
4vHPV WLWH
AS04-HPV-16/18 without HIV
4vHPV without HIV
GMC 95%CI GMC 95%CI GMC 95%CI GMC 95%CI
VISIT1 (D0) 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6
VISIT2 (W6) 30.3 22.6 40.5 22.9 17.2 30.6 53.2 44.2 63.9 35.2 30.0 41.2
VISIT3 (W10) 343.5 275.6 428.2 194.9 151.9 250.2 578.0 472.5 707.0 357.1 293.7 434.3
VISIT5 (M7) 752.3 566.2 999.5 354.9 269.5 467.4 2123.6 1621.0 2782.1 777.9 611.2 990.1
VISIT6 (M12) 189.1 140.2 255.1 92.2 68.1 124.8 642.7 504.6 818.8 274.9 226.2 334.1
VISIT7 (M18) 119.1 89.9 157.7 43.5 32.1 58.9 348.3 284.6 426.4 118.6 98.8 142.4
VISIT8 (M24) 96.8 71.7 130.7 33.7 25.0 45.5 281.8 226.8 350.2 91.5 76.2 109.9

anti-HPV-18 antibody (IU/mL) AS04-HPV-16/18 WLWH
4vHPV WLWH
AS04-HPV-16/18 without HIV
4vHPV without HIV
GMC 95%CI GMC 95%CI GMC 95%CI GMC 95%CI
VISIT1 (D0) 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6
VISIT2 (W6) 19.8 15.2 25.8 7.0 5.3 9.3 45.2 37.2 54.9 9.8 8.1 11.7
VISIT3 (W10) 280.6 225.7 348.8 40.5 30.9 53.2 457.4 373.4 560.3 85.1 68.7 105.3
VISIT5 (M7) 486.6 381.5 620.7 82.8 60.9 112.6 1010.8 777.7 1313.7 217.4 170.2 277.7
VISIT6 (M12) 121.2 91.7 160.2 18.0 13.1 24.6 278.7 219.2 354.2 60.9 48.3 76.9
VISIT7 (M18) 69.9 52.9 92.5 9.1 6.8 12.3 156.3 126.3 193.3 25.8 20.8 32.0
VISIT8 (M24) 53.4 39.2 72.8 8.0 6.0 10.6 132.8 106.9 164.9 19.7 15.9 24.5

ATP: according to protocol;D: Day; CI: confidence interval; GMC: geometric mean concentration; HIV: human immunodeficiency virus; HPV: human papillomavirus; IU: International unit; M: Month; W: Week; WLWH: women living with HIV.